Pharmacological Approaches in Neurofibromatosis Type 1-Associated Nervous System Tumors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological Approaches in Neurofibromatosis Type 1-Associated Nervous System Tumors
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 15, Pages 3880
Publisher
MDPI AG
Online
2021-08-02
DOI
10.3390/cancers13153880
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial
- (2021) Michael J. Fisher et al. NATURE MEDICINE
- Deregulated microRNAs in neurofibromatosis type 1 derived malignant peripheral nerve sheath tumors
- (2020) Azadeh Amirnasr et al. Scientific Reports
- Phase II study of oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study
- (2020) Nicole J Ullrich et al. NEURO-ONCOLOGY
- Selumetinib in Children with Inoperable Plexiform Neurofibromas
- (2020) Andrea M. Gross et al. NEW ENGLAND JOURNAL OF MEDICINE
- Longitudinal phenotype development in a minipig model of neurofibromatosis type 1
- (2020) Johanna Uthoff et al. Scientific Reports
- Distinct Tumor Microenvironments Are a Defining Feature of Strain-Specific CRISPR/Cas9-Induced MPNSTs
- (2020) Amanda Scherer et al. Genes
- Overcoming BET inhibitor resistance in malignant peripheral nerve sheath tumors
- (2019) Lu Q. Le et al. CLINICAL CANCER RESEARCH
- Epigenomic reordering induced by Polycomb loss drives oncogenesis but leads to therapeutic vulnerabilities in malignant peripheral nerve sheath tumors
- (2019) John B Wojcik et al. CANCER RESEARCH
- Feasibility of using NF1-GRD and AAV for gene replacement therapy in NF1-associated tumors
- (2019) Ren-Yuan Bai et al. GENE THERAPY
- Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
- (2019) Jason Fangusaro et al. LANCET ONCOLOGY
- Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell–specific chemokine recruitment of T cells and microglia
- (2019) Xiaofan Guo et al. NEURO-ONCOLOGY
- Trametinib Induces Neurofibroma Shrinkage and Enables Surgery
- (2019) Pia Vaassen et al. NEUROPEDIATRICS
- RUNX represses Pmp22 to drive neurofibromagenesis
- (2019) Ashley Hall et al. Science Advances
- NFKB1-miR-612-FAIM2 pathway regulates tumorigenesis in neurofibromatosis type 1
- (2019) Meng Wang et al. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
- RUNX transcription factors: orchestrators of development
- (2019) Renaud Mevel et al. DEVELOPMENT
- The Role of Non-coding RNAs in Oncology
- (2019) Frank J. Slack et al. CELL
- Clinical spectrum of individuals with pathogenic N F1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype–phenotype study in neurofibromatosis type 1
- (2019) Magdalena Koczkowska et al. HUMAN MUTATION
- Optic Pathway Glioma in Type 1 Neurofibromatosis: Review of Its Pathogenesis, Diagnostic Assessment, and Treatment Recommendations
- (2019) Matteo Cassina et al. Cancers
- Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844–848
- (2018) Magdalena Koczkowska et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis
- (2018) Lai Man Natalie Wu et al. CANCER CELL
- Therapeutic Immune Modulation Against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial
- (2018) Chrisann Kyi et al. CLINICAL CANCER RESEARCH
- Athymic mice reveal a requirement for T-cell–microglia interactions in establishing a microenvironment supportive ofNf1low-grade glioma growth
- (2018) Yuan Pan et al. GENES & DEVELOPMENT
- LGG-41. BEVACIZUMAB FOR PEDIATRIC LOW GRADE GLIOMA
- (2018) Keita Terashima et al. NEURO-ONCOLOGY
- Cutaneous neurofibromas
- (2018) Nicolas Ortonne et al. NEUROLOGY
- Considerations for development of therapies for cutaneous neurofibroma
- (2018) Sharad K. Verma et al. NEUROLOGY
- Imatinib prevents lung cancer metastasis by inhibiting M2-like polarization of macrophages
- (2018) Zhangting Yao et al. PHARMACOLOGICAL RESEARCH
- Gene therapy comes of age
- (2018) Cynthia E. Dunbar et al. SCIENCE
- Ras-Specific GTPase-Activating Proteins—Structures, Mechanisms, and Interactions
- (2018) Klaus Scheffzek et al. Cold Spring Harbor Perspectives in Medicine
- The molecular landscape of glioma in patients with Neurofibromatosis 1
- (2018) Fulvio D’Angelo et al. NATURE MEDICINE
- STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma
- (2018) Jonathan S. Fletcher et al. ONCOGENE
- Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial
- (2018) John M. Slopis et al. Drugs in research & development
- Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma
- (2018) Nataliya Zhukova et al. Cancer Medicine
- Emerging genotype–phenotype relationships in patients with large NF1 deletions
- (2017) Hildegard Kehrer-Sawatzki et al. HUMAN GENETICS
- CNS Tumors in Neurofibromatosis
- (2017) Jian Campian et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors
- (2017) Azadeh Amirnasr et al. PLoS One
- Targeted inhibition of glutaminase as a potential new approach for the treatment of NF1 associated soft tissue malignancies
- (2017) Tahir N. Sheikh et al. Oncotarget
- Whole tumor RNA-sequencing and deconvolution reveal a clinically-prognostic PTEN/PI3K-regulated glioma transcriptional signature
- (2017) Yuan Pan et al. Oncotarget
- Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications
- (2017) Martina Musella et al. OncoImmunology
- The genomic landscape of malignant peripheral nerve sheath tumors: diverse drivers of Ras pathway activation
- (2017) Andrew S. Brohl et al. Scientific Reports
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases
- (2016) Consuelo M. López de Padilla et al. GENE
- PDCT-02. MARKED RECOVERY OF VISION IN A CHILD WITH OPTIC PATHWAY GLIOMA TREATED UPFRONT WITH BEVACIZUMAB AND VINBLASTINE
- (2016) Magimairajan Issai Vanan et al. NEURO-ONCOLOGY
- Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas
- (2016) Regina I. Jakacki et al. NEURO-ONCOLOGY
- Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas
- (2016) Eva Dombi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation
- (2016) Angela C. Hirbe et al. Oncotarget
- Ketotifen suppression of NF1 neurofibroma growth over 30 years
- (2015) Vincent M. Riccardi AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Oncolytic measles virus as a novel therapy for malignant peripheral nerve sheath tumors
- (2015) David R. Deyle et al. GENE
- Runx1 contributes to neurofibromatosis type 1 neurofibroma formation
- (2015) H Li et al. ONCOGENE
- Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of neurofibromatosis type 1
- (2015) Edwin Jousma et al. PEDIATRIC BLOOD & CANCER
- RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth
- (2015) Anne C. Solga et al. NEOPLASIA
- Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity
- (2015) Adrienne L. Watson et al. Oncotarget
- The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
- (2014) X. Varelas DEVELOPMENT
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Neurofibromatosis type 1: a multidisciplinary approach to care
- (2014) Angela C Hirbe et al. LANCET NEUROLOGY
- PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies
- (2014) Thomas De Raedt et al. NATURE
- PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors
- (2014) William Lee et al. NATURE GENETICS
- Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus
- (2014) Slawomir Antoszczyk et al. NEURO-ONCOLOGY
- Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
- (2014) B. C. Widemann et al. NEURO-ONCOLOGY
- Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth
- (2014) Aparna Kaul et al. NEURO-ONCOLOGY
- Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a Neurofibromatosis Clinical Trials Consortium phase II study
- (2014) B. Weiss et al. NEURO-ONCOLOGY
- Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
- (2014) Brigitte C. Widemann et al. PEDIATRIC BLOOD & CANCER
- Nilotinib Is More Potent than Imatinib for Treating Plexiform Neurofibroma In Vitro and In Vivo
- (2014) Jiang Wei et al. PLoS One
- BET Bromodomain Inhibition Triggers Apoptosis of NF1-Associated Malignant Peripheral Nerve Sheath Tumors through Bim Induction
- (2014) Amish J. Patel et al. Cell Reports
- Toll-Like Receptor Signaling Pathways
- (2014) Takumi Kawasaki et al. Frontiers in Immunology
- MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis
- (2013) Julien Masliah-Planchon et al. BMC GENOMICS
- Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
- (2013) Adrienne L. Watson et al. Cancer Discovery
- Marked Recovery of Vision in Children With Optic Pathway Gliomas Treated With Bevacizumab
- (2013) Robert A. Avery et al. JAMA Ophthalmology
- Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition
- (2012) Carlos E. Prada et al. ACTA NEUROPATHOLOGICA
- Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation
- (2012) Winnie W. Pong et al. ANNALS OF NEUROLOGY
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- Prognostic Significance of AKT/mTOR and MAPK Pathways and Antitumor Effect of mTOR Inhibitor in NF1-Related and Sporadic Malignant Peripheral Nerve Sheath Tumors
- (2012) M. Endo et al. CLINICAL CANCER RESEARCH
- MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors
- (2012) Walter J. Jessen et al. JOURNAL OF CLINICAL INVESTIGATION
- Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial
- (2012) Kent A Robertson et al. LANCET ONCOLOGY
- Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1
- (2012) M. Kolberg et al. NEURO-ONCOLOGY
- Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas
- (2012) Eugene I. Hwang et al. PEDIATRIC BLOOD & CANCER
- Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas
- (2012) AeRang Kim et al. PEDIATRIC BLOOD & CANCER
- Pathogenesis of Plexiform Neurofibroma: Tumor-Stromal/Hematopoietic Interactions in Tumor Progression
- (2011) Karl Staser et al. Annual Review of Pathology-Mechanisms of Disease
- Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven Tumors
- (2011) Thomas De Raedt et al. CANCER CELL
- Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989
- (2011) D Gareth R Evans et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Expression of ‘drugable’ tyrosine kinase receptors in malignant peripheral nerve sheath tumour: potential molecular therapeutic targets for a chemoresistant cancer
- (2011) Keila E. Torres et al. HISTOPATHOLOGY
- Pediatric Plexiform Neurofibromas: Impact on Morbidity and Mortality in Neurofibromatosis Type 1
- (2011) Carlos E. Prada et al. JOURNAL OF PEDIATRICS
- Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression
- (2011) Mina J Bissell et al. NATURE MEDICINE
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- Mortality associated with neurofibromatosis type 1: A study based on Italian death certificates (1995-2006)
- (2011) Maria Masocco et al. Orphanet Journal of Rare Diseases
- Lenalidomide mode of action: linking bench and clinical findings
- (2010) Faith Davies et al. BLOOD REVIEWS
- MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1
- (2010) Guolin Chai et al. CANCER SCIENCE
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Preclinicalin vivoevaluation of rapamycin in human malignant peripheral nerve sheath explant xenograft
- (2009) Priya Bhola et al. INTERNATIONAL JOURNAL OF CANCER
- Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours
- (2009) Subbaya Subramanian et al. JOURNAL OF PATHOLOGY
- Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas
- (2009) A. Kim et al. NEUROLOGY
- Preclinical Cancer Therapy in a Mouse Model of Neurofibromatosis-1 Optic Glioma
- (2008) B. Hegedus et al. CANCER RESEARCH
- Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/−- and c-kit-Dependent Bone Marrow
- (2008) Feng-Chun Yang et al. CELL
- TORC1 Is Essential for NF1-Associated Malignancies
- (2008) Cory M. Johannessen et al. CURRENT BIOLOGY
- Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors
- (2008) G. Johansson et al. MOLECULAR CANCER THERAPEUTICS
- EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy
- (2008) Nikola Holtkamp et al. NEURO-ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started